Sino Biopharmaceutical Li... (SBMFF)

PNK: SBMFF · Real-Time Price · USD

0.49

-0.00 (-0.81%)

At close: Apr 22, 2025, 10:13 AM

Sino Biopharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	7.94B	7.94B	n/a	7.14B	7.14B	4.04B	6.79B	7.6B	7.6B	6.25B	6.25B	7.11B	7.24B	5.52B	5.48B	6.43B	6.22B	4.91B	6.79B	6.32B	6.21B	5.16B	6B	5.07B	4.65B	3.37B	3.96B	3.62B	3.86B	3.57B	3.72B	3.4B	3.51B
Cost of Revenue	1.42B	1.42B	n/a	1.3B	1.3B	110.06M	1.42B	1.48B	1.48B	1.29B	1.29B	1.34B	1.42B	1.11B	1.28B	1.53B	1.27B	1.16B	1.32B	1.24B	1.21B	1.11B	1.23B	916.28M	942.22M	693.35M	828.86M	759.32M	809.09M	742.02M	745.96M	732.92M	749.5M
Gross Profit	6.51B	6.51B	n/a	5.84B	5.84B	3.93B	5.38B	6.12B	6.12B	4.96B	4.96B	5.77B	5.83B	4.41B	4.2B	4.9B	4.96B	3.76B	5.47B	5.08B	5B	4.05B	4.78B	4.16B	3.71B	2.68B	3.14B	2.86B	3.05B	2.83B	2.98B	2.67B	2.76B
Operating Income	1.8B	1.8B	n/a	1.56B	1.56B	915.86M	1.36B	1.63B	1.63B	1.03B	1.03B	1.78B	1.26B	755.64M	1.11B	1.42B	1.05B	911.46M	1.72B	1.33B	1.13B	416.62M	1.84B	1.32B	1.04B	831.14M	1.1B	1.33B	667.75M	1.15B	1.37B	1.67B	521.9M
Interest Income	n/a	n/a	n/a	3.08M	3.08M	15.51M	15.51M	22.35M	22.35M	86.21M	86.21M	45.27M	54.04M	26.2M	54.48M	75.47M	77.3M	101.84M	52.92M	60.09M	42.87M	54.48M	43.48M	39.68M	25.08M	25.93M	26.46M	17.26M	13.4M	15.8M	9.09M	8M	7.79M
Pretax Income	1.81B	1.81B	n/a	1.53B	1.53B	448.26M	1.01B	1.88B	1.88B	3.8B	3.8B	8.14B	2.84B	1.27B	1.19B	1.29B	1.29B	1.1B	1.85B	1.39B	1.24B	7.15B	1.88B	1.31B	1.09B	1.18B	1.33B	921.64M	762.62M	930.58M	1.05B	799.92M	561.38M
Net Income	1.51B	1.51B	n/a	629.39M	629.39M	-173.2M	311.27M	960.52M	960.52M	3.06B	3.06B	6.57B	1.91B	920.59M	637.42M	351.06M	875.79M	451.28M	811.17M	587.65M	856.7M	6.85B	835.59M	594.57M	771.1M	365.99M	704.38M	521.57M	579.01M	372.93M	477.18M	422.78M	427.56M
Selling & General & Admin	3.42B	3.42B	n/a	3.22B	3.22B	1.96B	2.82B	3.47B	3.47B	2.96B	2.96B	3.18B	3.5B	2.97B	2.94B	2.76B	2.93B	2.6B	3.34B	3.01B	2.97B	3.23B	2.6B	2.24B	2.2B	1.76B	1.72B	1.65B	1.77B	1.79B	1.65B	1.63B	1.74B
Research & Development	1.29B	1.29B	n/a	1.18B	1.18B	1.05B	1.14B	1.02B	1.02B	982.74M	982.74M	767.05M	1.01B	699.74M	386.4M	566.75M	973.82M	n/a	428.79M	760.94M	864.61M	388.06M	374.33M	716.38M	611.8M	130M	313.64M	n/a	616.66M	n/a	n/a	n/a	479.7M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-236.52M	154.55M	n/a	250.88M	n/a	n/a	29.55M	n/a	n/a	11.48M	24.19M	-43.68M	5.2M	-128.06M	-712.34M	-109.74M	-47.87M	-632.63M	8.04M
Operating Expenses	4.71B	4.71B	n/a	4.4B	4.4B	3.46B	4.38B	4.26B	4.26B	3.94B	3.94B	5.77B	5.83B	3.66B	4.2B	3.48B	3.93B	2.85B	3.76B	3.75B	3.86B	3.63B	2.94B	2.97B	2.83B	1.85B	2.04B	1.53B	1.67B	1.68B	1.61B	994.89M	2.24B
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	75.56M	71.66M	n/a	91.14M	83.89M	90.43M	96.65M	47.07M	51.12M	35.11M	43.88M	58.23M	27.4M	23.76M	24.78M	19.04M	17.06M	17.06M	25.74M	26.14M	14.15M	14.16M
Selling & Marketing Expenses	2.9B	2.9B	n/a	2.69B	2.69B	1.75B	2.3B	2.88B	2.88B	2.43B	2.43B	2.61B	3.05B	2.11B	2.25B	2.12B	2.49B	1.72B	2.66B	2.48B	2.45B	1.81B	2.29B	1.99B	1.99B	1.16B	1.59B	1.53B	1.64B	1.3B	1.48B	1.46B	1.48B
Cost & Expenses	6.14B	6.14B	n/a	5.58B	5.58B	3.12B	5.8B	5.97B	5.97B	5.23B	5.23B	5.4B	5.93B	4.8B	4.6B	4.83B	5.17B	4.02B	5.09B	5.01B	5.04B	4.74B	4.2B	3.87B	3.75B	2.59B	2.86B	2.29B	2.48B	2.42B	2.35B	1.73B	2.99B
Income Tax Expense	307.05M	307.05M	n/a	249M	249M	23.03M	102.3M	285.7M	285.7M	310.48M	310.48M	889.97M	446.94M	-105.31M	239.8M	325.64M	216.47M	57.19M	382.61M	237.44M	212.21M	-87.99M	355.44M	270.19M	158.58M	38M	218.66M	130.01M	155.63M	79.1M	213.06M	91.38M	114.47M
Shares Outstanding (Basic)	39.39B	39.39B	18.55B	18.57B	18.57B	16.05B	21.03B	20.87B	20.87B	20.52B	20.52B	19.26B	20.62B	18.58B	18.87B	18.8B	23.76B	18.59B	18.88B	18.89B	18.89B	18.36B	18.94B	18.95B	17.96B	14.4B	17.44B	18.2B	16.68B	16.68B	16.68B	16.68B	16.68B
Shares Outstanding (Diluted)	18.41B	18.41B	18.57B	18.56B	18.56B	18.91B	18.91B	19.12B	19.12B	19.28B	19.28B	19.29B	19.29B	18.58B	19.01B	19.49B	18.87B	18.6B	18.88B	18.89B	18.89B	18.36B	18.93B	18.96B	17.96B	14.4B	17.44B	18.2B	16.68B	16.68B	16.68B	16.68B	16.68B
EPS (Basic)	0.02	0.04	n/a	0.03	0.03	-0.01	0.01	0.05	0.05	0.15	0.15	0.34	0.09	0.07	0.05	0.05	0.05	0.06	0.04	0.03	0.05	0.37	0.04	0.03	0.04	0.03	0.04	0.03	0.03	0.02	0.03	0.03	0.03
EPS (Diluted)	0.04	0.04	n/a	0.03	0.03	-0.01	0.02	0.05	0.05	0.16	0.16	0.34	0.10	0.07	0.05	0.05	0.05	0.06	0.04	0.03	0.05	0.37	0.04	0.03	0.04	0.03	0.04	0.03	0.03	0.02	0.03	0.03	0.03
EBITDA	1.98B	1.98B	n/a	1.81B	1.81B	1.11B	1.61B	1.77B	1.77B	1.02B	1.02B	8.21B	2.91B	1.33B	1.28B	1.79B	1.38B	1.2B	1.9B	1.45B	1.27B	657.49M	1.94B	1.34B	1.11B	1.21B	1.35B	938.71M	779.69M	956.33M	1.07B	814.07M	575.67M
EBIT	1.73B	1.73B	n/a	1.52B	1.52B	864.76M	1.36B	1.58B	1.58B	805.68M	805.68M	8.21B	2.91B	1.33B	1.28B	1.37B	1.38B	1.2B	1.9B	1.45B	1.27B	7.2B	1.94B	1.34B	1.11B	1.21B	1.35B	938.71M	779.69M	956.33M	1.07B	814.07M	575.67M
Depreciation & Amortization	240.6M	240.6M	-36.81K	295.01M	295.01M	246.4M	246.4M	187.88M	187.88M	210.79M	210.79M	199.5M	n/a	n/a	n/a	421.57M	330.53M	n/a	n/a	n/a	n/a	290.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a